Pulmonx Q3 EPS $(0.39) Vs. $(038) Prior Year, Sales $17.67M Beat $16.39M Estimate

pulmonx +5.35%





Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.39) per share. This is a 2.63 percent decrease over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $17.67 million which beat the analyst consensus estimate of $16.39 million by 7.80 percent. This is a 30.85 percent increase over sales of $13.50 million the same period last year.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via